Edwards Lifesciences Corp Stock Net Income
| EW Stock | USD 70.34 0.29 0.41% |
Edwards Lifesciences Corp fundamentals help investors to digest information that contributes to Edwards Lifesciences' financial success or failures. It also enables traders to predict the movement of Edwards Stock. The fundamental analysis module provides a way to measure Edwards Lifesciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Edwards Lifesciences stock.
| Last Reported | Projected for Next Year | ||
| Net Income | 4.2 B | 4.4 B | |
| Net Income Applicable To Common Shares | 1.8 B | 1.8 B | |
| Net Income From Continuing Ops | 1.4 B | 883 M | |
| Net Income Per Share | 6.98 | 7.33 | |
| Net Income Per E B T | 2.70 | 2.83 |
Edwards | Net Income |
Edwards Lifesciences Corp Company Net Income Analysis
Edwards Lifesciences' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Edwards Lifesciences Net Income | 4.17 B |
Most of Edwards Lifesciences' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Edwards Lifesciences Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Edwards Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Edwards Lifesciences is extremely important. It helps to project a fair market value of Edwards Stock properly, considering its historical fundamentals such as Net Income. Since Edwards Lifesciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Edwards Lifesciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Edwards Lifesciences' interrelated accounts and indicators.
Edwards Net Income Historical Pattern
Today, most investors in Edwards Lifesciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Edwards Lifesciences' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's net income growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Edwards Lifesciences net income as a starting point in their analysis.
Edwards Lifesciences Net Income |
| Timeline |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Edwards Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Edwards Lifesciences Corp reported net income of 4.17 B. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is significantly lower than that of the firm.
Edwards Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Edwards Lifesciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Edwards Lifesciences could also be used in its relative valuation, which is a method of valuing Edwards Lifesciences by comparing valuation metrics of similar companies.Edwards Lifesciences is currently under evaluation in net income category among its peers.
Edwards Lifesciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Edwards Lifesciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Edwards Lifesciences' managers, analysts, and investors.Environmental | Governance | Social |
Edwards Lifesciences Institutional Holders
Institutional Holdings refers to the ownership stake in Edwards Lifesciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Edwards Lifesciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Edwards Lifesciences' value.| Shares | Jennison Associates Llc | 2024-12-31 | 7.5 M | Ninety One Uk Limited | 2024-12-31 | 7.2 M | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 7.1 M | Deutsche Bank Ag | 2024-12-31 | 6.9 M | Ubs Asset Mgmt Americas Inc | 2024-12-31 | 6.5 M | Northern Trust Corp | 2024-12-31 | 6.5 M | Marshall Wace Asset Management Ltd | 2024-12-31 | 5.8 M | Wellcome Trust Ltd | 2024-12-31 | 4.8 M | Jacobs Levy Equity Management, Inc. | 4.6 M | Vanguard Group Inc | 2024-12-31 | 69.1 M | Blackrock Inc | 2024-12-31 | 54.5 M |
Edwards Fundamentals
| Return On Equity | 0.17 | ||||
| Return On Asset | 0.0826 | ||||
| Profit Margin | 0.77 % | ||||
| Operating Margin | 0.26 % | ||||
| Current Valuation | 37.46 B | ||||
| Shares Outstanding | 587.9 M | ||||
| Shares Owned By Insiders | 0.91 % | ||||
| Shares Owned By Institutions | 88.96 % | ||||
| Number Of Shares Shorted | 8.49 M | ||||
| Price To Earning | 32.77 X | ||||
| Price To Book | 4.07 X | ||||
| Price To Sales | 7.63 X | ||||
| Revenue | 5.44 B | ||||
| Gross Profit | 4.32 B | ||||
| EBITDA | 1.72 B | ||||
| Net Income | 4.17 B | ||||
| Cash And Equivalents | 769 M | ||||
| Cash Per Share | 2.81 X | ||||
| Total Debt | 700 M | ||||
| Debt To Equity | 0.11 % | ||||
| Current Ratio | 3.83 X | ||||
| Book Value Per Share | 16.99 X | ||||
| Cash Flow From Operations | 542.3 M | ||||
| Short Ratio | 1.95 X | ||||
| Earnings Per Share | 2.34 X | ||||
| Price To Earnings To Growth | 5.41 X | ||||
| Target Price | 80.38 | ||||
| Number Of Employees | 15.8 K | ||||
| Beta | 1.12 | ||||
| Market Capitalization | 41.52 B | ||||
| Total Asset | 13.06 B | ||||
| Retained Earnings | 13.17 B | ||||
| Working Capital | 4.78 B | ||||
| Current Asset | 2.05 B | ||||
| Current Liabilities | 476.2 M | ||||
| Net Asset | 13.06 B |
About Edwards Lifesciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Edwards Lifesciences Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Edwards Lifesciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Edwards Lifesciences Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Edwards Stock Analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.